Salivary rheumatoid factor in primary and secondary Sjögren’s syndrome.

Autores

  • Gloria Martínez-Sandoval School of Dentistry, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
  • Silvia Triana-Reyes School of Dentistry, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
  • Norma Rodríguez-Franco School of Dentistry, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
  • María Chapa-Arizpe School of Dentistry, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
  • Jesús Rodríguez-Pulido School of Dentistry, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
  • Andrea Alcázar-Pizaña Centro de Investigación y Desarrollo en Ciencias de la Salud, Monterrey, Nuevo León, México.
  • Janett Riega-Torres Centro de Especialistas en Artritis y Reumatismo, Hospital Universitario. Monterrey, Nuevo León, México.

DOI:

https://doi.org/10.17126/%25x

Resumo

Sjögren's syndrome is a chronic autoimmune disease, characterized by the presence of hyposalivation and xerophthalmia, which in addition to other factors is diagnosed by the presence of rheumatoid factor in blood. The objective of the present study is to evaluate the presence of rheumatoid factor (IgG-IgM) in the saliva of patients with primary and secondary Sjögren's syndrome. Materials and methods: Forty samples from patients with primary and secondary Sjögren's syndrome previously diagnosed by the Arthritis and Rheumatism Specialist Center of the Autonomous University of Nuevo Leon were analyzed. Samples were taken from the saliva using the Carlson-Crittenden device to evaluate the IgG-IgM immunocomplex using the ELISA method. Results: No significant difference was found between the presence of IgM in primary (0.099±0.016) and secondary Sjögren syndrome (0.098±0.017), however, a high presence of IgG was found in the group of patients with secondary Sjögren's syndrome (0.134±0.054). Conclusion: The search for diagnostic tools using salivary biomarkers has come with economic and clinical advantages, however, in the present study no significant changes were found in salivary rheumatoid factor between both groups.

Downloads

Não há dados estatísticos.

Publicado

2019-06-30

Como Citar

1.
Martínez-Sandoval G, Triana-Reyes S, Rodríguez-Franco N, Chapa-Arizpe M, Rodríguez-Pulido J, Alcázar-Pizaña A, Riega-Torres J. Salivary rheumatoid factor in primary and secondary Sjögren’s syndrome. J Oral Res [Internet]. 30º de junho de 2019 [citado 3º de julho de 2024];8(3):196-200. Disponível em: https://revistas.udec.cl/index.php/journal_of_oral_research/article/view/1749

Edição

Seção

Articles

##plugins.generic.recommendByAuthor.heading##